Effects of Ulinastatin on Myocardial Protection and Blood Loss in Patients Undergoing Aortic Valve Replacement
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
According to TEG (thromboelastography), as maximum amplitude is increased the amount of
bleeding and transfusion and Cardiac enzyme is reduced by using ulinastatin.